Literature DB >> 29748370

Letter by Mitchell et al Regarding Article, "Urinary Prostaglandin Metabolites: An Incomplete Reckoning and a Flush to Judgment".

Jane A Mitchell1, Rebecca B Knowles2, Nicholas S Kirkby1, Daniel M Reed1, Matthew L Edin3, William E White4, Melissa V Chan2, Hilary Longhurst5, Magdi M Yaqoob4, Ginger L Milne6, Darryl C Zeldin3, Timothy D Warner2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29748370      PMCID： PMC5985955          DOI： 10.1161/CIRCRESAHA.118.312976

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  15 in total

1.  A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease.

Authors:  Erik Lerkevang Grove; Anne-Mette Hvas; Helle Ladefoged Johnsen; Sofie Sommer Hedegaard; Susanne Bendesgaard Pedersen; Jette Mortensen; Steen Dalby Kristensen
Journal:  Thromb Haemost       Date:  2010-03-29       Impact factor: 5.249

2.  Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs.

Authors:  I A Reilly; G A FitzGerald
Journal:  Blood       Date:  1987-01       Impact factor: 22.113

Review 3.  Prostaglandins.

Authors:  B Samuelsson; E Granström; K Green; M Hamberg; S Hammarström
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

4.  Urinary Prostaglandin Metabolites: An Incomplete Reckoning and a Flush to Judgment.

Authors:  Tilo Grosser; Ali Naji; Garret A FitzGerald
Journal:  Circ Res       Date:  2018-02-16       Impact factor: 17.367

5.  Dose- and time-dependent antiplatelet effects of aspirin.

Authors:  Christina Perneby; N Håkan Wallén; Cathy Rooney; Desmond Fitzgerald; Paul Hjemdahl
Journal:  Thromb Haemost       Date:  2006-04       Impact factor: 5.249

Review 6.  Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology.

Authors:  Wiktor Kuliczkowski; Adam Witkowski; Lech Polonski; Cezary Watala; Krzysztof Filipiak; Andrzej Budaj; Jacek Golanski; Dariusz Sitkiewicz; Jerzy Pregowski; Jacek Gorski; Marian Zembala; Grzegorz Opolski; Kurt Huber; Harald Arnesen; Steen D Kristensen; Raffaele De Caterina
Journal:  Eur Heart J       Date:  2009-01-27       Impact factor: 29.983

7.  Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance".

Authors:  Francesca Santilli; Bianca Rocca; Raimondo De Cristofaro; Stefano Lattanzio; Laura Pietrangelo; Aida Habib; Caterina Pettinella; Antonio Recchiuti; Elisabetta Ferrante; Giovanni Ciabattoni; Giovanni Davì; Carlo Patrono
Journal:  J Am Coll Cardiol       Date:  2009-02-24       Impact factor: 24.094

8.  Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.

Authors:  Sofie S Hedegaard; Anne-Mette Hvas; Erik L Grove; Jens Refsgaard; Bianca Rocca; Giovanni Daví; Steen D Kristensen
Journal:  Thromb Res       Date:  2009-02-11       Impact factor: 3.944

9.  Cyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular system.

Authors:  Nicholas S Kirkby; Martina H Lundberg; Louise S Harrington; Philip D M Leadbeater; Ginger L Milne; Claire M F Potter; Malak Al-Yamani; Oladipupo Adeyemi; Timothy D Warner; Jane A Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

10.  Systematic study of constitutive cyclooxygenase-2 expression: Role of NF-κB and NFAT transcriptional pathways.

Authors:  Nicholas S Kirkby; Melissa V Chan; Anne K Zaiss; Eliana Garcia-Vaz; Jing Jiao; Lisa M Berglund; Elena F Verdu; Blerina Ahmetaj-Shala; John L Wallace; Harvey R Herschman; Maria F Gomez; Jane A Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-28       Impact factor: 11.205
View more
  2 in total

1.  Mechanistic definition of the cardiovascular mPGES-1/COX-2/ADMA axis.

Authors:  Nicholas S Kirkby; Joan Raouf; Blerina Ahmetaj-Shala; Bin Liu; Sarah I Mazi; Matthew L Edin; Mark Geoffrey Chambers; Marina Korotkova; Xiaomeng Wang; Walter Wahli; Darryl C Zeldin; Rolf Nüsing; Yingbi Zhou; Per-Johan Jakobsson; Jane A Mitchell
Journal:  Cardiovasc Res       Date:  2020-10-01       Impact factor: 10.787

Review 2.  Prostanoid Metabolites as Biomarkers in Human Disease.

Authors:  Helena Idborg; Sven-Christian Pawelzik
Journal:  Metabolites       Date:  2022-08-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.